Poseida Therapeutics, Inc. Operating Lease Liability
Poseida Therapeutics, Inc. had Operating Lease Liability of $23.82 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2024-11-07
- 2024-09-30: Operating Lease, Liability $23.82M.
- 2024-06-30: Operating Lease, Liability $24.86M.
- 2024-03-31: Operating Lease, Liability $25.87M.
- 2023-12-31: Operating Lease, Liability $26.83M.
| Period end | Operating Lease, Liability |
|---|---|
| 2024-09-30 | $23.82M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $24.86M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $25.87M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $26.83M 10-K · filed 2024-03-07 |
| 2023-09-30 | $27.77M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $28.68M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $29.57M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $30.50M 10-K · filed 2023-03-09 |
| 2022-09-30 | $32.47M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $33.49M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $35.23M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $31.84M 10-K · filed 2022-03-10 |
| 2021-09-30 | $30.81M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $31.73M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $32.62M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $30.18M 10-K · filed 2021-03-11 |
| 2020-09-30 | $29.81M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $25.37M 10-Q · filed 2020-08-20 |